BTIS
GSK icon

BB&T Investment Services’s GSK GSK Stock Holding History

BB&T Investment Services’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$905K Buy
20,612
+3,154
+18% +$146K 0.15% 137
2017
Q3 		$890K Buy
17,458
+7,043
+68% +$357K 0.18% 119
2017
Q2 		$556K Buy
10,415
+4,028
+63% +$215K 0.14% 141
2017
Q1 		$341K Sell
6,387
-91
-1% -$4.62K 0.13% 151
2016
Q4 		$313K Buy
+6,478
New +$320K 0.23% 105

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BB&T Investment Services's GSK Position: Q4 2017 in Review

BB&T Investment Services increased its GSK (GSK) stake by 18% in Q4 2017, buying an estimated $146K and bringing the position to 20,612 shares worth $905K. The position accounts for 0.15% of the portfolio, ranked #137.

BB&T Investment Services first reported a position in GSK in Q4 2016 and has held it in 5 quarters since. 763 funds tracked by Wall St. Rank hold GSK as of Q4 2017.

  • BB&T Investment Services held 20,612 shares of GSK worth $905K as of Q4 2017.
  • BB&T Investment Services bought 3,154 GSK shares in Q4 2017, an estimated $146K.
  • GSK made up 0.15% of BB&T Investment Services's portfolio in Q4 2017, its #137 holding.
  • BB&T Investment Services first reported a position in GSK in Q4 2016 and has held it in 5 quarters since.
  • 763 funds tracked by Wall St. Rank held GSK as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.